Evidence map›Paper›PMID 28738961›Full record

ArticleZhongguo fei ai za zhi = Chinese journal of lung cancer2017

[Circular RNA CircHIPK3 Promotes NCI-H1299 and NCI-H2170 Cell Proliferation through miR-379 and its Target IGF1].

Fang Tian, Yun Wang, Zhe Xiao, Xuejun Zhu

Open access · greenAbstract read
In one paragraph

Article in Zhongguo fei ai za zhi = Chinese journal of lung cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 43 citations in OpenAlex.

  1. [Research Progress of Circular RNA CircHIPK3 in Non-small Cell Lung Cancer].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2024
    Review
  2. Review
  3. Circular RNAs as biomarkers for lung cancer.Non-coding RNA research · 2023
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Circular RNA circHIPK3 modulates prostate cancer progression via targeting miR-448/MTDH signaling.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2021
    Article
  9. CircRNAs: Insights into Gastric Cancer.Gastrointestinal tumors · 2021
    Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Circular RNA in Lung Cancer Research: Biogenesis, Functions, and Roles.International journal of biological sciences · 2020
    Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Fang TianState Key Laboratory of Cellular Stress Biology, School of Life Sciences, Xiamen University, Xiamen 361000, China;Dpartment of Respiratory Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, China.
Yun WangState Key Laboratory of Cellular Stress Biology, School of Life Sciences, Xiamen University, Xiamen 361000, China.
Zhe XiaoState Key Laboratory of Cellular Stress Biology, School of Life Sciences, Xiamen University, Xiamen 361000, China.
Xuejun ZhuDpartment of Respiratory Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, China.
Xiamen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIt has been proven that the circular RNA, possessing a stable covalently closed continuous loop, is a type of RNA molecule which is expressed widespread in mammals. The circular RNA circHIPK3 is abundantly expressed in hepatocellular carcinoma (HCC) and promotes tumourgenesis. However, a role for circHIPK3 has not been systematically examined in non-small cell lung cancer (NSCLC). In this study, we investigated whether circHIPK3 has an effect on cell proliferation in the NSCLC cell lines NCI-H1299 and NCI-H2170 and the underlying molecular mechanisms.

methodsThe expression of circHIPK3 was measured by real-time PCR in NSCLC cell lines. Nuclear mass separation experiment was used to detect the location of circHIPK3 in cells. The gain and loss function experiments were used to examine the proliferation of NCI-H1299 and NCI-H2170 cells by Cell Counting Kit-8 (CCK-8) and the colony formation assays. Then, circHIPK3 was cloned into the downstream of the luciferase reporter gene which activity was detected to verify whether miR-379 could bind with circHIPK3 or IGF1 mRNA. The protein level of IGF1 was detected by Western blot and ELISA in circHIPK3 overexpressed/knock-down NCI-H1299 and NCI-H2170 cells.

resultsCircHIPK3 was generally expressed in six kinds of NSCLC cells lines we detected, and the expression level was highest in H2170 and lowest in H1299. Overexpression of circHIPK3 obviously promoted NCI-H1299 cell proliferation and knock-down of circHIPK3 inhibited NCI-H2170 cell proliferation. In the luciferase assay, miR-379 was observed to sequester circHIPK3 and IGF1 mRNA with potential binding sites. Furthermore, we found that the overexpression of circHIPK3 could increase the expression levels of IGF1 and knock-down reduced it. Moreover, up-regulation of miR-379 rescued the phenotype induced by overexpression of circHIPK3.

conclusionsCircHIPK3 could promote cell proliferation by a circHIPK3/miR-379 pathway in NCI-H1299 and NCI-H2170 cells and might be a potential tumor biomarker for NSCLC.
.

Indexed as

ApoptosisCarcinoma, Non-Small-Cell LungCell Line, TumorCell ProliferationGene Expression Regulation, NeoplasticGene TargetingHumansInsulin-Like Growth Factor IIntracellular Signaling Peptides and ProteinsLung NeoplasmsMicroRNAsProtein Serine-Threonine KinasesRNARNA, CircularHIPK3 protein, humanIGF1 protein, humanInsulin-Like Growth Factor IIntracellular Signaling Peptides and ProteinsMicroRNAsMIRN379 microRNA, humanProtein Serine-Threonine KinasesRNARNA, Circular

Identifiers

PMID28738961
PMCPMC5972943
OpenAlexW2981454120

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.